{"nct_id":"NCT01854606","title":"Safety and Efficacy of AEB071 and EVEROLIMUS in Patients With CD79-mutant or ABC Subtype Diffuse Large B-Cell Lymphoma","status":"COMPLETED","status_verified_date":"2017-05","start_date":"2013-12-05","start_date_type":"ACTUAL","primary_completion_date":"2016-06-01","primary_completion_date_type":"ACTUAL","completion_date":"2016-06-01","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["NVS"]}